Danaher (NYSE:DHR) has announced a multi billion euro senior notes offering to fund its planned acquisition of Masimo ...

By Jonathan Stempel April 23 (Reuters) - Danaher reached a $172.5 million settlement with shareholders who accused the ...

Danaher Corp. has reached a nearly $173 million class settlement with investors who allege it misrepresented demand for its ...

On April 29, 2026, Danaher issued €3 billion in euro-denominated senior notes across four tranches, including floating-rate notes due 2028 and fixed-rate notes maturing between 2030 and 2038, as ...

If you are looking at Danaher and wondering whether the current share price reflects fair value, you are not alone. The stock ...

Danaher remains in focus as earnings resilience, diagnostics softness, and capital allocation concerns reshape sentiment ...

Danaher maintains strong FCF and profitability, but revenue growth remains stagnant, especially in Life Sciences and ...

Q1 2026 Earnings Call April 21, 2026 8:00 AM EDTCompany ParticipantsRachel VatnsdalRainer Blair - President, CEO ...

Danaher boosted the upper end of its full-year earnings guidance, following a first-quarter beat fueled by double-digit ...

Shares of Danaher popped more than 6% on Tuesday after the life sciences company delivered a strong quarter and reaffirmed its guidance — signaling the longtime Club stock is back on track. Revenue ...

If biotech funding continues to increase this year, Danaher could benefit.

Danaher shares are under pressure Wednesday as the Club holding's fourth-quarter earnings results came in mixed and guidance disappointed. The company long known for its operational excellence is ...